![Paul Reddell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul Reddell was the founder of EcoBiotics Ltd., founded in 2000, where the title held was Chief Scientific Officer.
Dr. Reddell is the founder of Qbiotics Group Ltd., founded in 2000, holding the title of Executive Director & Chief Scientific Officer.
The current job is Director at Qbiotics Pty Ltd. Education includes undergraduate and doctorate degrees from The University of Western Australia.
Postes actifs de Paul Reddell
| Sociétés | Poste | Début |
|---|---|---|
Qbiotics Group Ltd.
 Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Fondateur | 01/01/2000 |
Qbiotics Pty Ltd.
 Qbiotics Pty Ltd. Qbiotics Pty Ltd. is an Australian life sciences company specializing in the discovery and development of novel cell signalling small molecules. The company is based in Yungaburra, Australia. The company uses phenotypic screening to discover new solutions for challenging medical conditions, with a clinical focus on treatments for cancer and chronic wounds. Its lead oncology drug, tigilanol tiglate, targets solid tumours and is in phase II human clinical development, while a veterinary formulation is marketed as Stelfonta® in the USA and Australia. Qbiotics also has a wound healing drug candidate, EBC 1013, targeting chronic and acute wounds and burns, currently in phase I clinical development for venous leg ulcers. | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Reddell
| Sociétés | Poste | Fin |
|---|---|---|
EcoBiotics Ltd.
 EcoBiotics Ltd. Pharmaceuticals: GenericHealth Technology Manufactures bioactive products | Fondateur | - |
Formation de Paul Reddell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EcoBiotics Ltd.
EcoBiotics Ltd. Pharmaceuticals: GenericHealth Technology Manufactures bioactive products | Health Technology |
Qbiotics Pty Ltd.
Qbiotics Pty Ltd. Qbiotics Pty Ltd. is an Australian life sciences company specializing in the discovery and development of novel cell signalling small molecules. The company is based in Yungaburra, Australia. The company uses phenotypic screening to discover new solutions for challenging medical conditions, with a clinical focus on treatments for cancer and chronic wounds. Its lead oncology drug, tigilanol tiglate, targets solid tumours and is in phase II human clinical development, while a veterinary formulation is marketed as Stelfonta® in the USA and Australia. Qbiotics also has a wound healing drug candidate, EBC 1013, targeting chronic and acute wounds and burns, currently in phase I clinical development for venous leg ulcers. | |
Qbiotics Group Ltd.
Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Health Technology |
